𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

✍ Scribed by Henrik Ryberg; Jiyan An; Samuel Darko; Jonathan Llyle Lustgarten; Matt Jaffa; Vanathi Gopalakrishnan; David Lacomis; Merit Cudkowicz; Robert Bowser

Book ID
102533100
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
335 KB
Volume
42
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical perspectives of high-resolution
Clinical perspectives of high-resolution mass spectrometry–based proteomics in neuroscience—Exemplified in amyotrophic lateral sclerosis biomarker discovery research
✍ Titti Ekegren; Jörg Hanrieder; Jonas Bergquist 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 649 KB

## Abstract Biomarker discovery is a central application in today's proteomic research. There is an urgent need for valid biomarkers to improve diagnostic tools and treatment in many disorders, such as the rapidly progressing neurodegenerative disorder amyotrophic lateral sclerosis (ALS) that has a

Proteomics of human cerebrospinal fluid:
Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics
✍ A.C. Kroksveen; J.A. Opsahl; T.T. Aye; R.J. Ulvik; F.S. Berven 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 737 KB

There is an urgent need for novel biomarkers that can be used to improve the diagnosis, predict the disease progression, improve our understanding of the pathology or serve as therapeutic targets for neurodegenerative diseases. Cerebrospinal fluid (CSF) is in direct contact with the CNS and reflects